Lecture ‒ Antifibrotic Therapy: Future Cure for Portal Hypertension?

  1. Roberto de Franchis MD Editor
  1. Detlef Schuppan,
  2. Jae Jin Cho,
  3. Masahiko Koda and
  4. Eckhart G. Hahn

Published Online: 31 JAN 2008

DOI: 10.1002/9780470760154.ch8

Portal Hypertension III: Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies

Portal Hypertension III: Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies

How to Cite

Schuppan, D., Cho, J. J., Koda, M. and Hahn, E. G. (2001) Lecture ‒ Antifibrotic Therapy: Future Cure for Portal Hypertension?, in Portal Hypertension III: Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies (ed R. de Franchis), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470760154.ch8

Editor Information

  1. Gastroenterology and Gastrointestinal Endoscopy Service Department of Internal Medicine, University of Milan, and lRCCS Ospedale Maggiore Policlinico, Milan, Italy

Publication History

  1. Published Online: 31 JAN 2008
  2. Published Print: 1 JAN 2001

ISBN Information

Print ISBN: 9780632059188

Online ISBN: 9780470760154

SEARCH

Keywords:

  • antifibrotic therapy;
  • tissue molecules;
  • noncollagenous glycoproteins;
  • hepatocyte proliferation;
  • liver cell function

Summary

This chapter contains sections titled:

  • Pathogenesis of Liver Fibrosis

  • Potential Antifibrotic Agents

  • The Role of Vasoconstrictors and Vasorelaxants in Hepatic Fibrogenesis

  • Serum Markers of Liver Fibrosis